VX-407
VX24-407-002
Phase 2 small_molecule active
Quick answer
VX-407 for Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a Phase 2 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active